Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers

Aug. 21, 2000

United submits first sections of Uniprost NDA to FDA for pulmonary hypertension

Aug. 21, 2000

Researchers establish the effect of beta-blocker nebivolol on nitric oxide production

Aug. 21, 2000

Therapies aimed at reducing free radicals may innovate treatment of septic shock

Aug. 21, 2000

Smoking linked to increased TF expression in atherosclerotic plaques

Aug. 21, 2000

GenVec begins phase II trials of BioByPass in PVD

Aug. 18, 2000

Novel endothelin receptor antagonists under study at BASF

Aug. 16, 2000

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Aug. 11, 2000

Carvedilol surpasses metoprolol in long-term heart failure treatment

Aug. 11, 2000

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Aug. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...